Tel Aviv, March 3, 2022.  Amcham's Healthcare Committee Leadership Team met today with Ministry of Health (MoH) Director General Prof. Nachman Ash, Deputy DG, Dr. Osnat Luxenburg and other ministry top officials to follow up on the Committee suggestions for regulatory reforms in medical clinical trials approval process, and new drug registrations processes.  The MoH infomed us that on both fronts the MoH is leaning to accept Amcham's proposals to streamline the clinical trials registration process, and to adopt a Reliance model on new indications for previously registered drugs.  This is major news on both fronts and good news for patients and for the Pharma industry in Israel.

Back to top